Who are we?
GBF Strategy was founded by Dr Gordon McKenzie, an Engineer who has spent the last 20 years putting innovation into practice in the UK and internationally. Gordon specialises in Imaging and AI Strategy and commercialisation. You can download Gordon's current CV here, or read on for more in-depth information.
Dr McKenzie with members of the ADVANCE group at the EADV Meeting in Amsterdam. Advance is an EU Framework 7 funded program to develop functional imaging for cancer detection.
Left to right: Prof. Giovanni Pellacani, Jon Holmes, Richard Whitehead, Prof. Gregor Jemec, Nikki Steadman, Dr. Gordon McKenzie, Dr. Mette Mogensen, Dr. Martina Ulrich, Prof. Julia Welzel.
History
After completing his PhD in Medical Engineering at the University of Warwick, Gordon began his career at Sira Technology Ltd, offering R&D consultancy to companies in the biomedical sector. As a Sales Applications Engineer and Smart Optics Technology Translator, he helped clients build collaborations, access funding, and deliver complex technical projects with commercial relevance.
Gordon went on to co-found Michelson Diagnostics, where he played a central role in developing and commercialising OCT imaging systems to improve cancer care. His time there gave him a wide range of hands-on skills across early-stage product development, clinical trial design, regulatory planning, and international market access. During his time on the leadership team, the company raised over £13M in equity finance and brought several clinical imaging devices to market across the EU, US, and Australia.
In 2016, Gordon established GBF Strategy Ltd to support early-stage MedTech and diagnostics companies in aligning their innovations with real clinical needs and market demands. He brings particular expertise in optical diagnostics, AI applications development, and value proposition design, acting as a translator between clinical teams and engineering groups to ensure technical work leads to commercially viable outcomes.
Gordon is currently an Honorary Research Fellow at the University of Liverpool, supporting the development and commercialisation of the LDIR Wand, a mid-infrared imaging platform for cancer diagnosis and prognosis.